Cumberland Pharmaceuticals Inc.

NASDAQ:CPIX

Drug Manufacturers - Specialty & Generic

Healthcare
$6.57 -1.07%

-$0.06 today

Market cap
$98.52M
Beta
0.10
P/E (TTM)
-11.5
EPS (TTM)
-$0.48
52W Low $1.85High $6.61

Volume 0.16M

Average 0.97M

Income Statement

Follow revenue through to earnings.

Revenue

$44.52M

FY 2025 · Annual

+17.6% YoY

Operating Income

-$2.79M

FY 2025 · Annual

Net Income

-$2.84M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue35.99M42.01M39.55M37.87M44.52M
Cost of Revenue8.81M9.12M6.07M6.59M6.67M
Gross Profit27.17M32.89M33.49M31.28M37.85M
Gross Margin75.5%78.3%84.7%82.6%85.0%
Research & Development5.68M6.69M5.83M4.82M5.57M
Selling, General & Admin24.8M26.84M29.1M28.15M31.05M
Operating Expenses34.85M38.6M43.04M37.71M40.65M
Depreciation & Amortization4.61M5.33M8.1M6.04M5.29M
EBITDA(857.83K)332.92K2.49M182.42K2.96M
EBITDA Margin-2.4%0.8%6.3%0.5%6.6%
Operating Income(7.68M)(5.7M)(9.55M)(6.43M)(2.79M)
Operating Margin-21.3%-13.6%-24.2%-17.0%-6.3%
Interest Income26.08K98.41K286.85K334.44K476.75K
Interest Expense98.03K586K667.86K605.51K495.99K
Other Income / Expenses2.12M123.74K3.27M(33.98K)(32.46K)
Income Before Tax(5.56M)(5.58M)(6.28M)(6.47M)(2.82M)
Pre-Tax Margin-15.5%-13.3%-15.9%-17.1%-6.3%
Income Tax Expense34.89K68.85K45.77K(22.67K)40.26K
Net Income(3.51M)(5.57M)(6.28M)(6.48M)(2.84M)
Net Margin-9.7%-13.3%-15.9%-17.1%-6.4%
EPS (Basic)(0.24)(0.38)(0.44)(0.46)(0.19)
EPS (Diluted)(0.24)(0.38)(0.44)(0.46)(0.19)
Weighted Avg Shares14.9M14.56M14.3M14.06M14.96M
Weighted Avg Shares (Diluted)14.9M14.56M14.3M14.06M14.96M

CPIX Earnings Waterfall · TTM

NASDAQ:CPIX · Revenue to Net Income

Key Ratios

EPS$-0.49
Gross Margin83.0%
Net Margin-18.7%
P/E Ratio-9.3
P/S Ratio5.0

Analysis

$41.9M of revenue converted into -$7.2M of net income for the selected period. Gross margin is 83.0% and net margin is -18.7%, showing how much revenue survives after costs and taxes. EPS is $-0.49, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
10-QQuarterly reportNov 13, 2026
8-KCurrent reportNov 10, 2026
8-KCurrent reportOct 26, 2026
8-KCurrent reportOct 23, 2026
8-K/A8-K/A filingSep 11, 2026

How much revenue does CPIX generate?

Cumberland Pharmaceuticals Inc. (CPIX) reported $44.52M of revenue in fiscal 2025.

Is CPIX profitable?

Cumberland Pharmaceuticals Inc. (CPIX) reported -$2.84M of net income, with a net margin of -6.4%.